Skip to main content

Autoimmune disorders occur when the immune system mistakenly attacks the body's own tissues, leading to chronic inflammation and tissue damage. Common autoimmune diseases include rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and multiple sclerosis (MS). Traditional treatments involve immunosuppressive drugs and biologics, which can have significant side effects and variable effectiveness.

Erectile dysfunction (ED) affects over 30 million men in the U.S., with causes ranging from vascular issues to nerve damage. Traditional treatments like PDE5 inhibitors (e.g., Viagra) offer temporary relief but do not address underlying tissue damage. Regenerative therapies, including stem cells, platelet lysate (PL), and platelet-rich plasma (PRP), aim to restore erectile function by repairing damaged tissues and improving blood flow.

Androgenetic alopecia (AGA), commonly known as pattern hair loss, affects over 50 million men and 30 million women in the U.S. It is characterized by the progressive miniaturization of hair follicles due to genetic and hormonal factors, particularly sensitivity to dihydrotestosterone (DHT). Traditional treatments like minoxidil and finasteride can slow hair loss but often have limited efficacy and potential side effects.

COPD is a progressive respiratory condition that includes chronic bronchitis and emphysema. It affects over 250 million people worldwide and is a leading cause of disability and death. Standard treatments include bronchodilators, inhaled steroids, oxygen therapy, and pulmonary rehab, but these do not reverse lung damage. Regenerative approaches aim to reduce inflammation and potentially repair airway tissues.

Chronic lower back pain, often caused by degenerative disc disease (DDD), affects nearly 40% of adults over 40. Traditional options like NSAIDs, physical therapy, spinal fusion surgery, and steroid injections frequently offer limited or temporary relief. Regenerative medicine now provides alternatives such as intradiscal injections of MSCs or Platelet Lysate (PL), which aim to reduce inflammation and potentially restore disc integrity.